|
|
|
Enlightened understanding for patent expiry forecasting
|
|
 
|
|
|
Analogue off-patent planning
is a service, which aids patent expiry forecasting by providing
benchmark models for brand and generic performance, based
on the history and experience of recent patnet expiry events.
|
|
|
|
|
The Analogue off-patent planning
database holds penetration curves for over 100 molecules in
the retail sector whose patent expired from 1989 in the five
major markets.
Included in the service;
|
|
Penetration Curves - by revenue and dose unit
volume |
|
|
Product Characteristics
- Patent expiry date,
price differential between brand and first generic,
effects of strategy, technical barrier to entry
|
|
|
Market Criteria - chronic/acute usage,
leading diagnosis, number of generics on the market
|
|
|
Country Coverage - Canada,
USA, France, Germany, UK.
|
|
|
International
Standards - able to compare across countries and
drill down into specific country |
| |
Annual
Updates - 2000 edition available from November 2001
edition will be released in July/August 2001 |
|
|
|
|
|
Analogue off-patent planning
identifies the factors contributing to uptake of generics
or the maintenance of brand value, providing a valuable benchmark
for the expected uptake of generics as brands lose their patent
protection. Additional insight into the generic environment
for each country.
Analogue off-patent planning is supplied as an interactive
database allowing you to select new product benchmark models
based on 14 selection criteria and enables you to
|
|
create "What if" scenarios by changing the product or
market criteria of selection
|
|
|
Develop
patent expiry forecasts based using the selected benchmarks
as models for the brand erosion and generic penetration
likely to be achieved under current market conditions
|
|
|
|
|
|
For further
details please contact IMS HEALTH at +44 (0)0207 393 5757
Download
a ScreenCam demo.
Request further information
- click here...
|
|
|
|
